MSME (Udyam registered) Ministry of MSME
- Category
- Micro (2024-25)
- Udyam number
- UDYAM-GJ-01-0180656
Bombay Generics Private Limited - pharma in Ahmedabad, Gujarat, India. FY 2026 financials & compliance.
Revenue · FY 2024
₹14.83 Lakh
▼ 79% YoY
Net profit · FY 2024
₹7,135
Net margin 0.5%
EBITDA · FY 2024
₹16,533
EBITDA margin 1.1%
Authorised capital
₹50 Lakh
Registered with MCA
Paid-up capital
₹50 Lakh
Issued & subscribed
Open charges
₹15.09 Cr
Satisfied ₹5.23 Cr
Company age
37 yrs
Est. 1989
Directors on board
8
As per MCA filings
About Bombay Generics Private Limited
Data last updated:
Bombay Generics Private Limited is a private limited company based in Ahmedabad, Gujarat, India. It operates in the drug formulation and development segment of the pharmaceuticals sector. It was incorporated on 01 June 1989 and has been in existence for over 37 years.
The company is registered with the Registrar of Companies (ROC), Ahmedabad, under CIN U24231GJ1989PTC012305. Its GSTIN is 24AAACO2254M2ZG (Gujarat). The company holds 2 GST registrations, of which 1 is active.
The company has an authorised share capital of ₹50 Lakh and a paid-up capital of ₹50 Lakh. It was formerly known as Osho Pharma Pvt Ltd. It is led by directors including Krushnakant Bhalodia and Krunal Dilipkumar Sanghavi.
Its last annual general meeting (AGM) was held on 30 September 2025, and its latest financial statements are for the year ended 31 March 2025. The registered office is at Plot No 2404 Phase – IV G.I.D.C. Vatva, Ahmedabad, Gujarat, India – 382445.
As per the financials filed for FY 2024, the company reported a revenue of ₹14.83 Lakh, a decline of 79% compared to the previous year. For the same year it recorded a net profit of ₹7,135 (net margin 0.5%) and EBITDA of ₹16,533 (EBITDA margin 1.1%). Revenue has grown at a compounded annual rate (CAGR) of 217% over three years and 90% over five years.
The company is associated with 1 brand: Osho Pharma. As per MCA filings, the company has open charges of ₹15.09 Cr and satisfied charges of ₹5.23 Cr on record. Court records list 4 cases involving the company, including 2 filed by the company and 2 filed against it.
Bombay Generics Private Limited is registered as a micro enterprise under the Udyam registration framework (Reg. No. UDYAM-GJ-01-0180656). The current compliance status is marked as compliant by the Registrar of Companies. For more details, the company can be reached via its website oshopharma.com.
Company details
CIN U24231GJ1989PTC012305
Registration Number 012305
Incorporation Date 01 June 1989
ROC Ahmedabad
Listing Status Unlisted
Company Status Active
Date of Last AGM 30 September 2025
Date of Balance Sheet 31 March 2025
Compliance Status Active Compliant
MSME Classification Micro
Udyam Registration UDYAM-GJ-01-0180656
Key People
Krushnakant Bhalodia Director Krunal Dilipkumar Sanghavi Director Snehalbhai Jashwantbhai Shah Director Recognitions & Rankings of Bombay Generics
Contact details
Bombay Generics Private Limited's registered office is in Ahmedabad, Gujarat. Its website is oshopharma.com. Its e-mail address is in the company report.
- Email
- Website
- Registered AddressPlot No 2404 Phase – IV G.I.D.C. Vatva, Ahmedabad, Gujarat, India – 382445
- IndustryPharma, Drug Formulation & Development
To see the full contact details of Bombay Generics Private Limited, buy the company report.
Comprehensive company report
Bombay Generics Private Limited - one report that includes everything
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
₹799 ₹999 20% off excluding 18% GST
Secure checkout · GST invoice included
Brands
Bombay Generics operates one associated brand: Osho Pharma. Each brand links to its own profile.
| Brand | Description | Website |
|---|---|---|
| Osho Pharma manufactures and exports a wide range of dosage forms, with a focus on herbal products. | oshopharma.com |
Business activity
The main business activity of Bombay Generics is manufacturing. In detail, this covers chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products.
| Main activity group code | Main activity | Business activity code | Business activity | Share of turnover |
|---|---|---|---|---|
| C | Manufacturing | C6 | Chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products |
To see the full business activity and turnover split of Bombay Generics Private Limited, buy the company report.
Financials of Bombay Generics Private Limited
FY 2025 filings availableBombay Generics Private Limited reported revenue of ₹14.83 Lakh (down 79% YoY) for FY 2024.
Revenue · FY 2024
₹14.83 Lakh ▼ 79%
Net profit · FY 2024
₹7,135 margin 0.5%
EBITDA · FY 2024
₹16,533 margin 1.1%
Compounded Annual Growth Rate (CAGR)
Revenue CAGR growth
1 year
▼ 79%
3 years · compounded
▲ 217%
5 years · compounded
▲ 90%
EBITDA CAGR growth
1 year
▼ 98%
3 years · compounded
▲ 27%
5 years · compounded
▲ 15%
Revenue fell 79% in the latest year, but over five years it has grown at a compounded annual rate (CAGR) of 90%. EBITDA fell 98% in the latest year. Three- and five-year figures are compounded annual growth rates (CAGR): the steady yearly rate that links the first and the last year. All are worked out from the filed statements.
Financial Statement Summary
| Metrics | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 | FY 2019-20 |
|---|---|---|---|---|---|
| Profit and Loss Statement | |||||
| Revenue from Operations | |||||
| Other Income | |||||
| Total Revenue | |||||
| Cost of Materials Consumed | |||||
| Employee Benefit Expense | |||||
| Finance Costs | |||||
| Depreciation and Amortisation | |||||
| Other Expenses | |||||
| Total Expenses | |||||
| EBITDA | ₹16,533 | ||||
| Profit Before Tax | |||||
| Tax Expense | |||||
| Net Profit (PAT) | ₹7,135 | ||||
| Balance Sheet | |||||
| Share Capital | |||||
| Reserves and Surplus | |||||
| Net Worth (Total Equity) | |||||
| Long-term Borrowings | |||||
| Short-term Borrowings | |||||
| Trade Payables | |||||
| Total Liabilities | |||||
| Fixed Assets | |||||
| Investments | |||||
| Inventories | |||||
| Trade Receivables | |||||
| Cash and Bank Balance | |||||
| Total Assets | |||||
Financial Ratios
| Metrics | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 | FY 2019-20 |
|---|---|---|---|---|---|
| Profitability | |||||
| EBITDA Margin | 1.1% | ||||
| Net Profit Margin | 0.5% | ||||
| Return on Equity (ROE) | |||||
| Return on Capital Employed (ROCE) | |||||
| Return on Assets (ROA) | |||||
| Liquidity and Debt | |||||
| Current Ratio | |||||
| Quick Ratio | |||||
| Debt-to-Equity Ratio | |||||
| Interest Coverage Ratio | |||||
| Efficiency and Growth | |||||
| Asset Turnover | |||||
| Receivable Days | |||||
| Payable Days | |||||
| Inventory Days | |||||
| Revenue Growth | |||||
| Net Profit Growth | |||||
To see the full financial statements and ratios of Bombay Generics Private Limited, buy the company report.
Board of directors of Bombay Generics Private Limited
Bombay Generics has 8 current directors and 8 former directors. Current directors are listed first, with their designation and appointment date.
Current Directors
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Krushnakant Bhalodia Also directs: Aplus Engitech LLP, Auroma Life Science Private Limited, Zeon Biotech Private Limited and 2 more | Director | 01 Feb 2021 | 5 Years 8 Months | Current |
| Krunal Dilipkumar Sanghavi Also directs: Reneev Developers Private Limited | Director | 11 Jul 2016 | 10 Years 3 Months | Current |
| Snehalbhai Jashwantbhai Shah | Director | 11 Jul 2016 | 10 Years 3 Months | Current |
| Poojaben Bhalodiya | Director | 01 Feb 2021 | 5 Years 8 Months | Current |
| Dimpal Bhalodiya | Director | 01 Feb 2021 | 5 Years 8 Months | Current |
| Bharatkumar Babulal Patel | Director | 11 Jul 2016 | 10 Years 3 Months | Current |
Showing 6 of 8 current directors. View all directors
Auditor
Bombay Generics Private Limited is audited by D S KHATRI & CO for the financial year 2023.
| Auditor firm | Financial year | Firm registration number |
|---|---|---|
| D S KHATRI & CO | FY 2023 | 129786 |
Shareholding
The shareholding of Bombay Generics Private Limited is on record for 5 financial years, the latest being FY 2023, split between promoters, domestic institutions, foreign institutions, public shareholders and others.
| Shareholder category | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 |
|---|---|---|---|---|---|
| Promoters | |||||
| Domestic institutional investors (DII) | |||||
| Foreign institutional investors (FII) | |||||
| Public | |||||
| Others |
To see the full shareholding pattern of Bombay Generics Private Limited, buy the company report.
Charges & borrowings
Open charges
₹15.09 Cr
Satisfied charges
₹5.23 Cr
Breakdown by lending institutions
Latest charge details
| Date | Charge ID | Lender | Amount | Status | Modified or satisfied on |
|---|---|---|---|---|---|
| 13 May 2025 | 101100020 | Others | ₹15 Cr | Open | |
| 19 Jan 1990 | 90097389 | Gujrat State Financial Corporation | ₹8.73 Lakh | Open | |
| 02 Sep 2023 | 100800835 | Others | ₹4 Cr | Satisfied | |
| 12 Sep 2005 | 90101154 | Union Bank of India | ₹1.15 Cr | Satisfied | |
| 20 Nov 1990 | 90097441 | Union Bank of India | ₹2.5 Lakh | Satisfied |
To see the full charge records of Bombay Generics Private Limited, buy the company report.
Total charge records: 7 View all charges
Legal cases
Bombay Generics Private Limited has 4 court cases on record: 2 filed by Bombay Generics, 2 filed against it. All cases are disposed.
Total cases
4
Filed by the company
2
Filed against the company
2
Disposed
4
Cases by court
| Court | Cases | Against the company | Pending |
|---|---|---|---|
| District courts | 2 | 1 | 0 |
| High courts | 2 | 1 | 0 |
Cases on record (4 of 4)
| Court | Type of case | Party | Status |
|---|---|---|---|
| High Court, GUJARAT | Court case (AO) | Filed against the company by Osho Laboratories Pvt.Ltd. | Disposed |
| District court, Ahmedabad, Gujarat | Court case (CS CCC) | Filed by the company against Osho Laboratories Private Ltd. | Disposed |
| High Court, GUJARAT | Special civil application | Filed by the company against Union of India THR' Secretary and 11 others | Disposed |
| District court, North Goa, Goa | Court case (AOA) | Filed against the company by State | Disposed |
To see the full case history of Bombay Generics Private Limited, buy the company report.
Case records are compiled from court listings and may lag the court's own records. A case filed against a company is not a finding against it.
MSME payment delays
No delayed payments to MSME suppliers are on our record for Bombay Generics Private Limited; the supplier-wise MSME Form 1 check is in the company report Buy the company report.
GST
Bombay Generics has 2 GST registrations: 1 active and 1 cancelled or inactive.
Total GSTINs
2
Active
1
Cancelled / inactive
1
| GSTIN | State | Status | Registered on |
|---|---|---|---|
| 24AAACO2254M2ZG | Gujarat | Active | 21 Sep 2021 |
To see the full GST registrations and return filing status of Bombay Generics Private Limited, buy the company report.
Recent activity
Bombay Generics Private Limited has 16 board changes on record since 1989: 8 appointments and 8 cessations. The latest: Ankurkumar Gopalbhai Bhalodiya was appointed as Director on 01 Feb 2021.
AGM
Bombay Generics Private Limited last Annual general meeting of members was held on 30 Sep 2025 as per latest MCA records.
Charges
A charge with Others of Rs. 1,500.00 Lakh registered on 13 May 2025 with Charge ID 101100020 was modified on 30 Jul 2025.
Charges
A charge with Others amounted to Rs. 1,500.00 Lakh with Charge ID 101100020 was registered on 13 May 2025.
Filing
Bombay Generics Private Limited has filed its annual Financial statements for the year ended 31 Mar 2025 with Roc Ahmedabad.
Charges
A charge registered on 02 Sep 2023 via Charge ID 100800835 with Others was fully satisfied on 06 Jul 2024.
Charges
A charge with Others amounted to Rs. 400.00 Lakh with Charge ID 100800835 was registered on 02 Sep 2023.
Appointed
Ankurkumar Gopalbhai Bhalodiya was appointed as Director.
Appointed
Dimpal Bhalodiya was appointed as Director.
Appointed
Krushnakant Bhalodia was appointed as Director.
Appointed
Poojaben Bhalodiya was appointed as Director.
Ceased
Bhavin Agarwal Jaigovindbhai ceased to be Director.
Ceased
Bharatkumar Babulal Patel ceased to be Additional Director.
23 earlier events are in the company report.
Frequently asked questions
Bombay Generics is an active private limited company based in Ahmedabad, Gujarat, India. The company works in drug formulation and development, within the pharma industry. It was incorporated on 01 June 1989 (37+ years old) and is registered under CIN U24231GJ1989PTC012305.
Bombay Generics has 8 current directors:
- Krushnakant Bhalodia - Director
- Krunal Dilipkumar Sanghavi - Director
- Snehalbhai Jashwantbhai Shah - Director
- Poojaben Bhalodiya - Director
- Dimpal Bhalodiya - Director
- Bharatkumar Babulal Patel - Director
- Bakulkumar Jayantilal Padia - Director
- Ankurkumar Gopalbhai Bhalodiya - Director
The latest financial statements of Bombay Generics on record with the MCA are for the year ended 31 March 2025. Its last annual general meeting was held on 30 September 2025. Year-wise statements from 2015 are in the company report.
The GSTIN of Bombay Generics is 24AAACO2254M2ZG, registered in Gujarat. The company has 2 GST registrations in all, of which 1 is active and 1 is cancelled or inactive.
The CIN (Corporate Identification Number) of Bombay Generics is U24231GJ1989PTC012305. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
Bombay Generics has 4 court cases on record: 2 filed by the company and 2 filed against it. Most are in the district courts.
Bombay Generics was incorporated on 01 June 1989, making it 37+ years old. It is registered with the Registrar of Companies, Ahmedabad.
Ankurkumar Gopalbhai Bhalodiya was appointed as Director on 01 Feb 2021. Dimpal Bhalodiya was appointed as Director on 01 Feb 2021. Krushnakant Bhalodia was appointed as Director on 01 Feb 2021. Bombay Generics has 16 board changes on record in total.
Yes, Bombay Generics is registered as a micro enterprise under Udyam registration (number: UDYAM-GJ-01-0180656).
Bombay Generics can be reached through the website oshopharma.com. Its registered office is in Ahmedabad, Gujarat, India.